The structural basis for amyloid formation by plasma apolipoproteins: a review

被引:74
作者
Hatters, DM [1 ]
Howlett, GJ [1 ]
机构
[1] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia
来源
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS | 2002年 / 31卷 / 01期
关键词
amyloid; apolipoproteins; amphipathic alpha-helix; conformational stability; atherosclerosis;
D O I
10.1007/s002490100172
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The formation of amyloid and other protein deposits in vivo is synonymous with many pathological conditions such as Alzheimer's disease, Creutzfeldt-Jakob disease and Parkinson's disease, Interestingly, many plasma apolipoproteins are also associated with amyloid deposits, including apolipoprotein (apo) A-I apoA-II and apoE. Apolipoproteins share a number of structural and conformational properties, namely a large proportion of class A amphipathic alpha-helices and limited conformational stability in the absence of lipid. Other proteins that form amyloid such as alpha-synuclein and serum amyloid A also contain amphipathic alpha-helical domains similar to those found in apolipoproteins. In this review we develop a hypothesis to account for the widespread occurrence of apolipoproteins in amyloid deposits. We describe the conformational stability of human apoC-II and the stabilization or alpha-helical structure in the presence of phospholipid. We propose that lipid-free apoC-II forms partially folded intermediates prone to amyloid formation. Parameters that affect apolipoprotein lipid binding in vivo, such as protein and lipid oxidation or protein truncations and mutations, could promote apolipoprotein-related pathologies including those associated within amyloid deposits of atherosclerotic plaques.
引用
收藏
页码:2 / 8
页数:7
相关论文
共 70 条
[1]  
AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249
[2]  
ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248
[3]   Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1 [J].
Asl, LH ;
Liepnieks, JJ ;
Asl, KH ;
Uemichi, T ;
Moulin, G ;
Desjoyaux, E ;
Loire, R ;
Delpech, M ;
Grateau, G ;
Benson, MD .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :221-227
[4]   A new human hereditary amyloidosis: The result of a stop-codon mutation in the apolipoprotein AII gene [J].
Benson, MD ;
Liepnieks, JJ ;
Yazaki, M ;
Yamashita, T ;
Asl, KH ;
Guenther, B ;
Kluve-Beckerman, B .
GENOMICS, 2001, 72 (03) :272-277
[5]  
BOOTH DR, 1995, QJM-INT J MED, V88, P695
[6]   Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein Al gene [J].
Booth, DR ;
Tan, SY ;
Booth, SE ;
Tennent, GA ;
Hutchinson, WL ;
Hsuan, JJ ;
Totty, NF ;
Truong, O ;
Soutar, AK ;
Hawkins, PN ;
Bruguera, M ;
Caballeria, J ;
Sole, M ;
Campistol, JM ;
Pepys, MB .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2714-2721
[7]   Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis [J].
Booth, DR ;
Sunde, M ;
Bellotti, V ;
Robinson, CV ;
Hutchinson, WL ;
Fraser, PE ;
Hawkins, PN ;
Dobson, CM ;
Radford, SE ;
Blake, CCF ;
Pepys, MB .
NATURE, 1997, 385 (6619) :787-793
[8]   APOLIPOPROTEIN-E CARBOXYL-TERMINAL FRAGMENTS ARE COMPLEXED TO AMYLOID-A AND AMYLOID-L - IMPLICATIONS FOR AMYLOIDOGENESIS AND ALZHEIMERS-DISEASE [J].
CASTANO, EM ;
PRELLI, F ;
PRAS, M ;
FRANGIONE, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) :17610-17615
[9]   Designing conditions for in vitro formation of amyloid protofilaments and fibrils [J].
Chiti, F ;
Webster, P ;
Taddei, N ;
Clark, A ;
Stefani, M ;
Ramponi, G ;
Dobson, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3590-3594
[10]   Acceleration of amyloid fibril formation by specific binding of A beta-(1-40) peptide to ganglioside-containing membrane vesicles [J].
ChooSmith, LP ;
GarzonRodriguez, W ;
Glabe, CG ;
Surewicz, WK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :22987-22990